Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	supercoiled DNA binding	HMGB1 ABL1	4.99e-05	6	37	2	GO:0097100
GeneOntologyMolecularFunction	DNA secondary structure binding	HMGB1 ABL1 H1-0	5.95e-05	41	37	3	GO:0000217
GeneOntologyMolecularFunction	ADP-D-ribose modification-dependent protein binding	MACROH2A1 XRCC1	6.97e-05	7	37	2	GO:0160002
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	PRDM2 SETBP1 ASH1L	7.36e-05	44	37	3	GO:0140938
GeneOntologyMolecularFunction	bubble DNA binding	HMGB1 ABL1	9.29e-05	8	37	2	GO:0000405
GeneOntologyMolecularFunction	histone H3K9 methyltransferase activity	PRDM2 ASH1L	2.57e-04	13	37	2	GO:0046974
GeneOntologyMolecularFunction	nucleosomal DNA binding	MACROH2A1 HMGN3 H1-0	2.59e-04	67	37	3	GO:0031492
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	PRDM2 SETBP1 ASH1L	2.70e-04	68	37	3	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	PRDM2 SETBP1 ASH1L	2.82e-04	69	37	3	GO:0016278
GeneOntologyMolecularFunction	5S rRNA binding	HMGB1 RPL4	3.00e-04	14	37	2	GO:0008097
GeneOntologyMolecularFunction	histone methyltransferase activity	PRDM2 SETBP1 ASH1L	3.07e-04	71	37	3	GO:0042054
GeneOntologyMolecularFunction	four-way junction DNA binding	HMGB1 ABL1	5.60e-04	19	37	2	GO:0000400
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETBP1 ASH1L	6.22e-04	20	37	2	GO:0042800
GeneOntologyMolecularFunction	cytoskeletal protein binding	APC KIFAP3 PHACTR2 ABL1 MYLK MAP6 REEP3 ARHGEF7	7.59e-04	1099	37	8	GO:0008092
GeneOntologyMolecularFunction	nucleosome binding	MACROH2A1 HMGN3 H1-0	7.89e-04	98	37	3	GO:0031491
GeneOntologyMolecularFunction	histone modifying activity	PHF2 PRDM2 SETBP1 ASH1L	8.27e-04	229	37	4	GO:0140993
GeneOntologyMolecularFunction	protein methyltransferase activity	PRDM2 SETBP1 ASH1L	9.12e-04	103	37	3	GO:0008276
GeneOntologyMolecularFunction	N-methyltransferase activity	PRDM2 SETBP1 ASH1L	9.64e-04	105	37	3	GO:0008170
GeneOntologyMolecularFunction	chromatin DNA binding	MACROH2A1 HMGN3 H1-0	3.62e-03	167	37	3	GO:0031490
GeneOntologyMolecularFunction	S-adenosylmethionine-dependent methyltransferase activity	PRDM2 SETBP1 ASH1L	3.94e-03	172	37	3	GO:0008757
GeneOntologyBiologicalProcess	chromatin organization	PHF2 HMGB1 MACROH2A1 ERCC6L DEK HMGN3 VCX PRDM2 SETBP1 H1-0 ASH1L	4.00e-07	896	38	11	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	PHF2 HMGB1 MACROH2A1 ERCC6L DEK HMGN3 VCX PRDM2 SETBP1 H1-0 ASH1L	1.17e-06	999	38	11	GO:0071824
GeneOntologyBiologicalProcess	chromatin remodeling	PHF2 HMGB1 MACROH2A1 ERCC6L DEK PRDM2 SETBP1 H1-0 ASH1L	6.07e-06	741	38	9	GO:0006338
GeneOntologyBiologicalProcess	regulation of rDNA heterochromatin formation	PHF2 MACROH2A1	9.90e-06	3	38	2	GO:0061187
GeneOntologyBiologicalProcess	brain development	PCSK1 TACC2 VCX2 VCX3B ABL1 VCX3A XRCC1 ARHGAP35 VCX	1.98e-05	859	38	9	GO:0007420
GeneOntologyBiologicalProcess	positive regulation of cell projection organization	APC ABL1 ARHGAP35 MAP6 ARHGEF7 RPL4 EIF4G2	2.87e-05	494	38	7	GO:0031346
GeneOntologyBiologicalProcess	positive regulation of DNA ligation	HMGB1 XRCC1	3.29e-05	5	38	2	GO:0051106
GeneOntologyBiologicalProcess	head development	PCSK1 TACC2 VCX2 VCX3B ABL1 VCX3A XRCC1 ARHGAP35 VCX	3.38e-05	919	38	9	GO:0060322
GeneOntologyBiologicalProcess	regulation of DNA ligation	HMGB1 XRCC1	4.93e-05	6	38	2	GO:0051105
GeneOntologyBiologicalProcess	rDNA heterochromatin formation	PHF2 MACROH2A1	1.47e-04	10	38	2	GO:0000183
GeneOntologyBiologicalProcess	nucleolar chromatin organization	PHF2 MACROH2A1	1.80e-04	11	38	2	GO:1990700
GeneOntologyBiologicalProcess	regulation of microtubule-based process	APC TACC2 ABL1 MAP6 ARHGEF7	1.91e-04	293	38	5	GO:0032886
GeneOntologyBiologicalProcess	heterochromatin formation	PHF2 HMGB1 MACROH2A1 H1-0	2.25e-04	163	38	4	GO:0031507
GeneOntologyBiologicalProcess	central nervous system development	PCSK1 TACC2 VCX2 VCX3B ABL1 VCX3A XRCC1 ARHGAP35 VCX	2.56e-04	1197	38	9	GO:0007417
GeneOntologyBiologicalProcess	positive regulation of binding	HMGB1 ABL1 ARHGEF7 H1-0	2.64e-04	170	38	4	GO:0051099
GeneOntologyBiologicalProcess	regulation of microtubule polymerization	APC ABL1 ARHGEF7	2.78e-04	69	38	3	GO:0031113
GeneOntologyBiologicalProcess	regulation of microtubule cytoskeleton organization	APC ABL1 MAP6 ARHGEF7	3.02e-04	176	38	4	GO:0070507
GeneOntologyBiologicalProcess	double-strand break repair via nonhomologous end joining	HMGB1 XRCC1 DEK	3.84e-04	77	38	3	GO:0006303
GeneOntologyBiologicalProcess	DNA ligation	HMGB1 XRCC1	3.90e-04	16	38	2	GO:0006266
GeneOntologyBiologicalProcess	regulation of axonogenesis	ARHGAP35 MAP6 RPL4 EIF4G2	4.19e-04	192	38	4	GO:0050770
GeneOntologyBiologicalProcess	gland development	PCSK1 APC PHF2 ABL1 ARHGAP35 ASH1L	5.04e-04	558	38	6	GO:0048732
GeneOntologyBiologicalProcess	negative regulation of gene expression, epigenetic	PHF2 HMGB1 MACROH2A1 H1-0	5.17e-04	203	38	4	GO:0045814
GeneOntologyBiologicalProcess	axonogenesis	APC ABL1 ARHGAP35 MAP6 RPL4 EIF4G2	5.44e-04	566	38	6	GO:0007409
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	APC ABL1 ARHGAP35 MAP6 ARHGEF7 RPL4 EIF4G2	6.52e-04	819	38	7	GO:0120039
GeneOntologyBiologicalProcess	nucleolus organization	PHF2 MACROH2A1	6.79e-04	21	38	2	GO:0007000
GeneOntologyBiologicalProcess	cell projection morphogenesis	APC ABL1 ARHGAP35 MAP6 ARHGEF7 RPL4 EIF4G2	6.86e-04	826	38	7	GO:0048858
GeneOntologyBiologicalProcess	regulation of anatomical structure morphogenesis	APC HMGB1 ABL1 ARHGAP35 MAP6 ARHGEF7 RPL4 EIF4G2	7.02e-04	1090	38	8	GO:0022603
GeneOntologyBiologicalProcess	regulation of cell size	ABL1 ARHGAP35 RPL4 EIF4G2	7.61e-04	225	38	4	GO:0008361
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	APC ABL1 ARHGAP35 MAP6 ARHGEF7 RPL4 EIF4G2	7.90e-04	846	38	7	GO:0120035
GeneOntologyBiologicalProcess	regulation of DNA repair	HMGB1 ABL1 XRCC1 DEK	8.80e-04	234	38	4	GO:0006282
GeneOntologyBiologicalProcess	regulation of cell projection organization	APC ABL1 ARHGAP35 MAP6 ARHGEF7 RPL4 EIF4G2	8.88e-04	863	38	7	GO:0031344
GeneOntologyBiologicalProcess	regulation of heterochromatin formation	PHF2 MACROH2A1	8.89e-04	24	38	2	GO:0031445
GeneOntologyBiologicalProcess	regulation of axon extension	ABL1 RPL4 EIF4G2	9.24e-04	104	38	3	GO:0030516
GeneOntologyCellularComponent	condensed chromosome	APC PHF2 KIFAP3 HMGB1 MACROH2A1 ERCC6L	2.07e-05	307	39	6	GO:0000793
HumanPheno	Infantile sensorineural hearing impairment	PRG4 SETBP1	4.22e-05	5	11	2	HP:0008610
HumanPheno	Synostosis of joints	APC MACROH2A1 AEBP1 SETBP1 ASH1L	4.48e-05	212	11	5	HP:0100240
MousePheno	lethality during fetal growth through weaning, incomplete penetrance	PCSK1 APC PHF2 EPS15L1 ELK3 ABL1 ARHGAP35 AEBP1 ERCC6L MAP6 SRRM4	1.63e-05	1124	31	11	MP:0011112
Domain	VCX/VCY1	VCX2 VCX3B VCX3A VCX	7.27e-11	5	38	4	IPR026653
Domain	VCX_VCY	VCX2 VCX3B VCX3A VCX	7.27e-11	5	38	4	PF15231
Domain	-	PCSK1 XRCC1 AEBP1	4.38e-04	73	38	3	2.60.120.260
Domain	Galactose-bd-like	PCSK1 XRCC1 AEBP1	9.17e-04	94	38	3	IPR008979
Domain	AT_hook	SETBP1 ASH1L	1.37e-03	27	38	2	SM00384
Domain	AT_hook_DNA-bd_motif	SETBP1 ASH1L	1.37e-03	27	38	2	IPR017956
Domain	ARM	APC KIFAP3	2.99e-03	40	38	2	SM00185
Domain	ARM_REPEAT	APC KIFAP3	2.99e-03	40	38	2	PS50176
Domain	SET	PRDM2 ASH1L	3.14e-03	41	38	2	PF00856
Domain	SET	PRDM2 ASH1L	3.94e-03	46	38	2	SM00317
Domain	Armadillo	APC KIFAP3	4.11e-03	47	38	2	IPR000225
Domain	SET_dom	PRDM2 ASH1L	4.64e-03	50	38	2	IPR001214
Domain	SET	PRDM2 ASH1L	4.64e-03	50	38	2	PS50280
Domain	Zinc_finger_PHD-type_CS	PHF2 ASH1L	7.73e-03	65	38	2	IPR019786
Domain	HMG_box_dom	HMGB1 NT5C1A	7.73e-03	65	38	2	IPR009071
Domain	PHD	PHF2 ASH1L	1.02e-02	75	38	2	PF00628
Domain	Znf_PHD-finger	PHF2 ASH1L	1.13e-02	79	38	2	IPR019787
Domain	PHD	PHF2 ASH1L	1.41e-02	89	38	2	SM00249
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	APC ARHGAP35 MYLK CHRM2 ARHGEF7	8.53e-06	150	27	5	M39520
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	APC ARHGAP35 MYLK CHRM2 ARHGEF7	9.10e-06	152	27	5	MM15834
Pathway	KEGG_BASE_EXCISION_REPAIR	HMGB1 XRCC1 HMGB1P1	3.94e-05	35	27	3	M5500
Pathway	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	APC ARHGAP35 MYLK CHRM2 ARHGEF7	4.63e-05	213	27	5	M18306
Pathway	REACTOME_APOPTOTIC_EXECUTION_PHASE	APC HMGB1 H1-0	1.09e-04	49	27	3	MM15448
Pathway	REACTOME_APOPTOTIC_EXECUTION_PHASE	APC HMGB1 H1-0	1.30e-04	52	27	3	M2341
Pathway	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	HMGB1 H1-0	2.30e-04	12	27	2	MM14554
Pathway	WP_HISTONE_MODIFICATIONS	PRDM2 SETBP1 ASH1L	2.53e-04	65	27	3	M39374
Pathway	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	HMGB1 H1-0	2.72e-04	13	27	2	M1018
Pubmed	A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation.	VCX2 VCX3B VCX3A VCX	1.50e-12	4	40	4	10903929
Pubmed	Analysis of the VCX3A, VCX2 and VCX3B genes shows that VCX3A gene deletion is not sufficient to result in mental retardation in X-linked ichthyosis.	VCX2 VCX3B VCX3A	1.41e-09	3	40	3	18076704
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	MACROH2A1 ELK3 PHACTR2 ABL1 XRCC1 MYLK PRG4 HMGN3	3.48e-09	329	40	8	17474147
Pubmed	A human sex-chromosomal gene family expressed in male germ cells and encoding variably charged proteins.	VCX2 VCX3A VCX	1.41e-08	5	40	3	10607842
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	APC EPS15L1 XRCC1 ARHGAP35 ERCC6L H1-0 ASH1L EIF4G2	1.00e-06	689	40	8	36543142
Pubmed	Modulation of neuritogenesis by a protein implicated in X-linked mental retardation.	VCX3B VCX3A	1.29e-06	2	40	2	19812318
Pubmed	Secreted HMGB1 from Wnt activated intestinal cells is required to maintain a crypt progenitor phenotype.	APC HMGB1	1.29e-06	2	40	2	27323825
Pubmed	Expression and localization of VCX/Y proteins and their possible involvement in regulation of ribosome assembly during spermatogenesis.	VCX3B VCX	1.29e-06	2	40	2	12862317
Pubmed	Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function.	ABL1 MYLK	1.29e-06	2	40	2	20861316
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	PHF2 MACROH2A1 XRCC1 DEK HMGN3 H1-0 ASH1L	2.30e-06	533	40	7	30554943
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EPS15L1 ELK3 ARHGAP35 ERCC6L PRG4 REXO1 PRDM2 EIF4G2	2.38e-06	774	40	8	15302935
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	APC PHF2 HMGB1 MACROH2A1 ARHGAP35 MAP6 DEK ARHGEF7 RPL4	3.03e-06	1082	40	9	38697112
Pubmed	Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance.	HMGB1 H1-0	3.87e-06	3	40	2	19158276
Pubmed	Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer.	APC HMGB1	3.87e-06	3	40	2	17599806
Pubmed	Arg kinase regulates prefrontal dendritic spine refinement and cocaine-induced plasticity.	ABL1 ARHGAP35	3.87e-06	3	40	2	22396406
Pubmed	DNA repair pathway profiling and microsatellite instability in colorectal cancer.	HMGB1 XRCC1	3.87e-06	3	40	2	16951227
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	APC EPS15L1 TACC2 MACROH2A1 ARHGAP35 MAP6 ARHGEF7 H1-0 EIF4G2	4.60e-06	1139	40	9	36417873
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PHF2 EPS15L1 MACROH2A1 ELK3 ANKRD12 ARHGAP35 REEP3 PCDH1 SETBP1 ASH1L	5.25e-06	1489	40	10	28611215
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	APC MACROH2A1 XRCC1 ERCC6L RPL4 PRDM2	5.98e-06	398	40	6	35016035
Pubmed	Nup358 interacts with APC and plays a role in cell polarization.	APC KIFAP3	7.73e-06	4	40	2	19654215
Pubmed	Identification of a link between the tumour suppressor APC and the kinesin superfamily.	APC KIFAP3	7.73e-06	4	40	2	11912492
Pubmed	An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth.	APC ABL1	7.73e-06	4	40	2	25834110
Pubmed	Insight into the Interplay of Gd-IgA1, HMGB1, RAGE and PCDH1 in IgA Vasculitis (IgAV).	HMGB1 PCDH1	7.73e-06	4	40	2	38673968
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PHF2 HMGB1 EPS15L1 MACROH2A1 XRCC1 DEK HMGB1P1 EIF4G2	1.10e-05	954	40	8	36373674
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	PHF2 HMGB1 XRCC1 DEK HMGN3 RPL4 PRDM2 H1-0 EIF4G2	1.28e-05	1294	40	9	30804502
Pubmed	The histone variant macroH2A confers functional robustness to the intestinal stem cell compartment.	APC MACROH2A1	1.29e-05	5	40	2	28934364
Pubmed	Analysis of histone variant constraint and tissue expression suggests five potential novel human disease genes: H2AFY2, H2AFZ, H2AFY, H2AFV, H1F0.	MACROH2A1 H1-0	1.29e-05	5	40	2	35072799
Pubmed	Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis.	HMGB1 PRG4	1.93e-05	6	40	2	19139395
Pubmed	Inhibition of Rho via Arg and p190RhoGAP in the postnatal mouse hippocampus regulates dendritic spine maturation, synapse and dendrite stability, and behavior.	ABL1 ARHGAP35	1.93e-05	6	40	2	17928439
Pubmed	Kinesin Kif3b mutation reduces NMDAR subunit NR2A trafficking and causes schizophrenia-like phenotypes in mice.	APC KIFAP3	1.93e-05	6	40	2	31746486
Pubmed	A shared promoter region suggests a common ancestor for the human VCX/Y, SPANX, and CSAG gene families and the murine CYPT family.	VCX3B VCX	1.93e-05	6	40	2	17342728
Pubmed	Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.	APC ABL1	2.70e-05	7	40	2	17318191
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	APC HMGB1 EPS15L1 ARHGAP35 MAP6 PCDH1 RPL4 H1-0 EIF4G2	2.84e-05	1431	40	9	37142655
Pubmed	TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA.	PHF2 HMGB1 DEK RPL4 H1-0	3.09e-05	317	40	5	30997501
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	MACROH2A1 MAP6 PCDH1 ARHGEF7 RPL4 EIF4G2	4.01e-05	558	40	6	35063084
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	EPS15L1 MACROH2A1 PHACTR2 PCDH1 C6orf132 EIF4G2	4.30e-05	565	40	6	25468996
Pubmed	Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.	MACROH2A1 SRRM4	5.77e-05	10	40	2	12800201
Pubmed	UbE2E1/UBCH6 Is a Critical in Vivo E2 for the PRC1-catalyzed Ubiquitination of H2A at Lys-119.	MACROH2A1 H1-0	7.05e-05	11	40	2	28073915
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	HMGB1 EPS15L1 ARHGAP35 DEK ARHGEF7 HMGN3 EIF4G2	7.50e-05	916	40	7	32203420
Pubmed	HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.	MACROH2A1 XRCC1	8.45e-05	12	40	2	27067600
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EPS15L1 TACC2 MACROH2A1 ARHGAP35 ERCC6L RPL4 EIF4G2	8.47e-05	934	40	7	33916271
Pubmed	The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity.	MACROH2A1 DEK	9.98e-05	13	40	2	17158748
Pubmed	Serine ADP-Ribosylation Depends on HPF1.	HMGB1 H1-0	1.34e-04	15	40	2	28190768
Pubmed	14-3-3sigma controls mitotic translation to facilitate cytokinesis.	DEK RPL4 H1-0	1.35e-04	86	40	3	17361185
Pubmed	Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.	KIFAP3 NT5C1A	1.53e-04	16	40	2	19451621
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PHF2 HMGB1 MACROH2A1 DEK RPL4 PRDM2 H1-0 EIF4G2	1.86e-04	1425	40	8	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	HMGB1 MACROH2A1 PHACTR2 MYLK HMGN3 RPL4 H1-0 ASH1L	2.01e-04	1442	40	8	35575683
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	APC HMGB1 MACROH2A1 ARHGEF7 RPL4	2.06e-04	475	40	5	31040226
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	APC TACC2 ANKRD12 MAP6 PRDM2 ASH1L EIF4G2	2.13e-04	1084	40	7	11544199
Pubmed	Adenomatous polyposis coli (APC) is required for normal development of skin and thymus.	APC KIFAP3	2.18e-04	19	40	2	17002498
Pubmed	Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.	APC EIF4G2	2.42e-04	20	40	2	21689717
Pubmed	The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis.	HMGB1 MYLK	3.21e-04	23	40	2	20207250
Pubmed	Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis.	PHF2 HMGB1 RPL4	3.26e-04	116	40	3	37117180
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	APC PHACTR2 ABL1 ERCC6L REEP3 C6orf132	4.23e-04	861	40	6	36931259
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	HMGB1 MACROH2A1 DEK	4.66e-04	131	40	3	34551306
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	APC PHF2 AEBP1 DEK H1-0 ASH1L	4.67e-04	877	40	6	20211142
Pubmed	Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.	ABL1 ARHGEF7	4.78e-04	28	40	2	18067320
Pubmed	Landscape of the SOX2 protein-protein interactome.	MACROH2A1 XRCC1 RPL4	5.20e-04	136	40	3	21280222
Pubmed	Isolation and characterization of proteins associated with histone H3 tails in vivo.	HMGB1 ASH1L	5.50e-04	30	40	2	17403666
Pubmed	Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3.	HMGB1 MACROH2A1 XRCC1 RPL4	5.68e-04	332	40	4	30595499
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	MACROH2A1 DEK C6orf132 H1-0	6.21e-04	340	40	4	29478914
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	HMGB1 MACROH2A1 HMGB1P1 H1-0 EIF4G2	6.33e-04	607	40	5	39147351
Pubmed	An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.	ELK3 DEK	6.66e-04	33	40	2	30783098
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	MACROH2A1 DEK RPL4 H1-0 EIF4G2	8.08e-04	641	40	5	36057605
Pubmed	Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.	MACROH2A1 HMGN3 HMGB1P1	8.18e-04	159	40	3	34537242
Pubmed	Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling.	HMGB1 MACROH2A1	8.37e-04	37	40	2	36835656
Pubmed	Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.	MACROH2A1 DEK	9.79e-04	40	40	2	28805822
Pubmed	Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.	APC XRCC1 PRDM2	9.93e-04	170	40	3	19064572
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	HMGB1 MACROH2A1 XRCC1 DEK HMGN3 EIF4G2	9.95e-04	1014	40	6	32416067
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	MACROH2A1 ABL1 CHRM2	1.01e-03	171	40	3	20201926
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	HMGB1 XRCC1 PRDM2	1.11e-03	177	40	3	26206133
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	MACROH2A1 XRCC1 DEK	1.13e-03	178	40	3	27637333
Interaction	H2BC9 interactions	HMGB1 MACROH2A1 PHACTR2 ERCC6L DEK HMGN3 RPL4 SETBP1 H1-0 ASH1L	6.92e-09	446	38	10	int:H2BC9
Interaction	SFN interactions	APC HMGB1 ABL1 ERCC6L REEP3 DEK RPL4 C6orf132 H1-0	4.20e-06	692	38	9	int:SFN
Interaction	PRNP interactions	APC KIFAP3 HMGB1 EPS15L1 XRCC1 ARHGAP35 MYLK ERCC6L H1-0 ASH1L EIF4G2	6.14e-06	1158	38	11	int:PRNP
Interaction	BRD2 interactions	PHF2 MACROH2A1 ELK3 XRCC1 ERCC6L DEK H1-0	1.35e-05	429	38	7	int:BRD2
Interaction	BRD3 interactions	PHF2 MACROH2A1 XRCC1 DEK HMGN3 RPL4 H1-0	3.33e-05	494	38	7	int:BRD3
Interaction	H3-3A interactions	PHF2 HMGB1 MACROH2A1 XRCC1 DEK PRDM2 H1-0 ASH1L	6.37e-05	749	38	8	int:H3-3A
Interaction	HPF1 interactions	HMGB1 MACROH2A1 H1-0	6.75e-05	42	38	3	int:HPF1
Interaction	NUP43 interactions	APC PHF2 MACROH2A1 PRDM2 H1-0 ASH1L EIF4G2	1.46e-04	625	38	7	int:NUP43
Interaction	H2AC14 interactions	MACROH2A1 DEK HMGN3 H1-0	1.53e-04	144	38	4	int:H2AC14
Interaction	VCX2 interactions	MACROH2A1 VCX2	1.54e-04	10	38	2	int:VCX2
Interaction	H3-4 interactions	PHF2 MACROH2A1 DEK REXO1 PRDM2 H1-0	1.76e-04	448	38	6	int:H3-4
Interaction	CDC14B interactions	PHF2 HMGB1 XRCC1 DEK	2.18e-04	158	38	4	int:CDC14B
Interaction	NUMA1 interactions	HMGB1 MACROH2A1 XRCC1 RPL4 PRDM2 H1-0	2.26e-04	469	38	6	int:NUMA1
Interaction	H3C1 interactions	KIFAP3 HMGB1 MACROH2A1 XRCC1 DEK PRDM2 H1-0 ASH1L	2.29e-04	901	38	8	int:H3C1
Cytoband	Ensembl 112 genes in cytogenetic band chrXp22	VCX2 VCX3B VCX3A VCX	6.72e-05	250	40	4	chrXp22
Cytoband	Xp22	VCX3A VCX	2.19e-04	25	40	2	Xp22
GeneFamily	Variable charge X/Y family	VCX2 VCX3B VCX3A VCX	5.90e-11	6	27	4	368
GeneFamily	Canonical high mobility group	HMGB1 HMGN3	1.17e-04	11	27	2	511
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	PRDM2 ASH1L	1.17e-03	34	27	2	487
GeneFamily	PHD finger proteins	PHF2 ASH1L	7.93e-03	90	27	2	88
GeneFamily	Histones	MACROH2A1 H1-0	1.29e-02	116	27	2	864
Coexpression	GSE14415_NATURAL_TREG_VS_TCONV_UP	APC TACC2 ARHGAP35 SETBP1 H1-0	4.41e-06	160	40	5	M2976
Coexpression	MURARO_PANCREAS_BETA_CELL	PCSK1 APC ANKRD12 PHACTR2 ARHGAP35 MAP6 RPL4 SETBP1 ASH1L	9.98e-06	946	40	9	M39169
Coexpression	GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN	ELK3 ANKRD12 ABL1 PRG4 RPL4	1.27e-05	199	40	5	M5682
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP	KIFAP3 PRG4 REEP3 HMGN3 C6orf132	1.30e-05	200	40	5	M9324
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL	PCSK1 TACC2 MAP6 SRRM4 SETBP1	5.29e-05	268	40	5	M45696
Coexpression	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	MYLK AEBP1 H1-0	5.78e-05	49	40	3	M2899
Coexpression	HADDAD_B_LYMPHOCYTE_PROGENITOR	ELK3 MYLK AEBP1 ARHGEF7 PRDM2	7.68e-05	290	40	5	M939
Coexpression	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	APC ARHGAP35 PRG4 ASH1L	8.44e-05	152	40	4	M2938
Coexpression	HAY_BONE_MARROW_PRO_B	HMGB1 MACROH2A1 DEK HMGN3 EIF4G2	9.58e-05	304	40	5	M39208
Coexpression	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	HMGB1 ELK3 EIF4G2	1.06e-04	60	40	3	M1515
Coexpression	BLUM_RESPONSE_TO_SALIRASIB_DN	APC HMGB1 MACROH2A1 MYLK DEK	1.64e-04	341	40	5	M2879
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL	APC AEBP1 ARHGEF7	1.68e-04	70	40	3	M45777
Coexpression	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2	HMGB1 DEK	1.75e-04	13	40	2	M17096
Coexpression	GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP	HMGB1 MACROH2A1 HMGN3 RPL4	1.76e-04	184	40	4	M6756
Coexpression	PUJANA_ATM_PCC_NETWORK	APC MACROH2A1 ELK3 ABL1 ARHGAP35 DEK HMGN3 RPL4 PRDM2	2.03e-04	1394	40	9	M9585
Coexpression	HOEGERKORP_CD44_TARGETS_DIRECT_DN	APC PRDM2	2.04e-04	14	40	2	M1823
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	APC KIFAP3 ANKRD12 ARHGAP35 MAP6 PCDH1 SRRM4 PRDM2	2.26e-04	1106	40	8	M39071
Coexpression	GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP	PCSK1 ANKRD12 PRG4 REEP3	2.38e-04	199	40	4	M3217
Coexpression	GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP	ABL1 MYLK RPL4 H1-0	2.38e-04	199	40	4	M5270
Coexpression	HALLMARK_MITOTIC_SPINDLE	APC KIFAP3 ABL1 ARHGEF7	2.38e-04	199	40	4	M5893
Coexpression	GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP	MACROH2A1 MYLK PRG4 HMGN3	2.38e-04	199	40	4	M3886
Coexpression	BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS	HMGB1 DEK RPL4	2.40e-04	79	40	3	M40003
Coexpression	GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	TACC2 MACROH2A1 ELK3 REEP3	2.42e-04	200	40	4	M302
Coexpression	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP	KIFAP3 XRCC1 DEK HMGN3	2.42e-04	200	40	4	M7077
Coexpression	GSE27786_BCELL_VS_NKTCELL_UP	PCSK1 APC XRCC1 ERCC6L	2.42e-04	200	40	4	M4808
Coexpression	GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP	ELK3 MAP6 PRG4 HMGN3	2.42e-04	200	40	4	M2933
Coexpression	GSE14350_IL2RB_KO_VS_WT_TREG_DN	ELK3 PRG4 HMGN3 H1-0	2.42e-04	200	40	4	M3422
Coexpression	WELCSH_BRCA1_TARGETS_UP	KIFAP3 DEK HMGN3 H1-0	2.47e-04	201	40	4	M5490
Coexpression	PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	HMGB1 MACROH2A1	3.82e-04	19	40	2	M1412
Coexpression	FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL	ELK3 REEP3 HMGN3 H1-0	4.26e-04	232	40	4	M41718
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	APC HMGB1 MACROH2A1 ARHGAP35 REEP3 DEK ARHGEF7 PRDM2	1.26e-05	595	40	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	APC KIFAP3 ANKRD12 MAP6 RPL4 SRRM4	2.01e-08	199	39	6	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	APC KIFAP3 ANKRD12 MAP6 RPL4 SRRM4	2.01e-08	199	39	6	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	ILEUM-non-inflamed-(6)_ILC-(6)_ILC3\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MACROH2A1 ELK3 PHACTR2 REEP3 RPL4	8.20e-07	199	39	5	ba144739f65560207303c0143e8de1e86922bebb
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK1 PHACTR2 MYLK CHRM2	1.83e-05	180	39	4	a407376209d80177bf7fc4200219030c83cb5f14
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	APC ANKRD12 PHACTR2 MYLK	2.08e-05	186	39	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Non-neuronal-Postmitotic-Red_blood_cells-Low_Quality-14\|World / Primary Cells by Cluster	PCSK1 RPL4 SRRM4 SETBP1	2.26e-05	190	39	4	feadd834d843f952aa7ced93899fd1f0868743df
ToppCell	Non-neuronal-Postmitotic-Red_blood_cells-Low_Quality\|World / Primary Cells by Cluster	PCSK1 RPL4 SRRM4 SETBP1	2.26e-05	190	39	4	31cf1367db5c04242621f7c98a10d094bc519e31
ToppCell	Non-neuronal-Postmitotic-Red_blood_cells\|World / Primary Cells by Cluster	PCSK1 RPL4 SRRM4 SETBP1	2.26e-05	190	39	4	f0b82334375749d917e440c493f10340c52ea13c
ToppCell	B_cell_maturation-CD34+_pre-plamsa\|B_cell_maturation / Lineage and Cell class	MACROH2A1 ELK3 MYLK H1-0	2.30e-05	191	39	4	4ee160a863d4fb9c4c9449633b9f337db8871992
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK1 MYLK AEBP1 PRG4	2.40e-05	193	39	4	5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0
ToppCell	Control-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	MYLK AEBP1 PRG4 SETBP1	2.45e-05	194	39	4	3c2266772c5b56e8e02a461e5193e29588028ee9
ToppCell	Control-Stromal-Myofibroblast\|Control / Disease state, Lineage and Cell class	MYLK AEBP1 PRG4 SETBP1	2.50e-05	195	39	4	ffcf76cd72e43d8cf1058a49c76e0956065038bc
ToppCell	Primary_Visual_cortex_(V1C)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK1 PHACTR2 CHRM2 H1-0	2.50e-05	195	39	4	24dbb125565facd2de42d848471d4867c81acf80
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ELK3 ANKRD12 PHACTR2 RPL4	2.55e-05	196	39	4	d4fd5513e98eec092d51199e7f054bc15a5eaa3d
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ELK3 ANKRD12 PHACTR2 RPL4	2.55e-05	196	39	4	3a08209210e1a8677097a78786e00062c81b1ad2
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ELK3 ANKRD12 PHACTR2 RPL4	2.55e-05	196	39	4	fddc3e89e7e6b093563655c2d02e86836cfd6da5
ToppCell	COVID-19_Convalescent-CD4+_Tcm\|COVID-19_Convalescent / Disease condition and Cell class	ELK3 ANKRD12 PHACTR2 RPL4	2.55e-05	196	39	4	f2a5eeb1cebde2762865ab29792370b751214c4d
ToppCell	COVID-19_Convalescent-Lymphoid_T/NK-CD4+_Tcm\|COVID-19_Convalescent / Disease group, lineage and cell class	ELK3 ANKRD12 PHACTR2 RPL4	2.55e-05	196	39	4	8caf4334ae692ce44e8fea5d606416afc5b72c00
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_Tcm\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	ELK3 ANKRD12 PHACTR2 RPL4	2.55e-05	196	39	4	7d841113a7161b017a08602d46366ac044271b34
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK AEBP1 PRG4 SETBP1	2.60e-05	197	39	4	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	CV-Moderate\|CV / Virus stimulation, Condition and Cluster	HMGB1 ELK3 AEBP1 RPL4	2.60e-05	197	39	4	8747a57ded96175a8365f066101ce2af80c8081d
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 MACROH2A1 DEK HMGN3	2.65e-05	198	39	4	8aa4149d2c1cec73cfd654db093252ec8ec5ef68
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HMGB1 ANKRD12 ASH1L EIF4G2	2.65e-05	198	39	4	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 MACROH2A1 AEBP1 HMGN3	2.71e-05	199	39	4	ea75804c34989c99aab542e6d72617ed144819b6
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 MACROH2A1 DEK HMGN3	2.71e-05	199	39	4	99778178e3ec121802db938db8c5475d19b43fec
ToppCell	10x5'v1-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 MACROH2A1 AEBP1 HMGN3	2.71e-05	199	39	4	713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell	Neuron\|World / Primary Cells by Cluster	KIFAP3 ANKRD12 MAP6 SRRM4	2.71e-05	199	39	4	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 MACROH2A1 DEK HMGN3	2.71e-05	199	39	4	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	KIFAP3 ANKRD12 MAP6 SRRM4	2.71e-05	199	39	4	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 MACROH2A1 DEK HMGN3	2.71e-05	199	39	4	fe3b7d540a644dfc6beea171c809b4d1ba4e188f
ToppCell	normal_Lung-T/NK_cells-Undetermined\|T/NK_cells / Location, Cell class and cell subclass	HMGB1 MACROH2A1 ERCC6L DEK	2.71e-05	199	39	4	4142d5b1b20212508f95841fdac4efb7655616cb
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 MACROH2A1 DEK HMGN3	2.71e-05	199	39	4	cdee798e3586e4e7a15de598239090a85752ea1e
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 MACROH2A1 AEBP1 DEK	2.71e-05	199	39	4	be425e9cb90a73289026b1b7cb581e1c02a8985e
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD4+_Tcm\|COVID-19_Convalescent / Disease, condition lineage and cell class	ELK3 ANKRD12 PHACTR2 RPL4	2.76e-05	200	39	4	99c5abfe96d791c60ae6021ab4201851ee4afc47
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYLK AEBP1 PRG4 SETBP1	2.76e-05	200	39	4	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYLK AEBP1 PRG4 CHRM2	2.76e-05	200	39	4	07641f476cb1a131c2a50258b88cc13bb38c8379
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYLK AEBP1 PRG4 CHRM2	2.76e-05	200	39	4	343fa6ba1f52d816d2e41466f674ff8360aecd81
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	ANKRD12 ARHGAP35 SRRM4 EIF4G2	2.76e-05	200	39	4	c6bbd33bca86ac7a76a7ba704b3e141237d04549
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYLK AEBP1 PRG4 SETBP1	2.76e-05	200	39	4	a510deaada669e690329183e18df02870bd204b3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK AEBP1 PRG4 CHRM2	2.76e-05	200	39	4	d0c00cdd52c2e001aec9b935f4e981ba77d0386a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	HMGB1 MACROH2A1 DEK HMGN3	2.76e-05	200	39	4	c00cc0b91baa37828895d9d6b8acbc6aa503215a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	HMGB1 MACROH2A1 DEK HMGN3	2.76e-05	200	39	4	9e1b62a703fb7d413ce580448a1df5127c28e8a7
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK AEBP1 PRG4 SETBP1	2.76e-05	200	39	4	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Chromophobe-6\|TCGA-Kidney / Sample_Type by Project: Shred V9	VCX2 VCX3A VCX	7.17e-05	92	39	3	965a0ebf4b1ad3eaad839b96995ea6712c5d3357
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	ANKRD12 SRRM4 EIF4G2	1.29e-04	112	39	3	9c3fb470708e76a8f8a3cb9aa17ab130c60fee11
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Mixed_Serous_and_Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	VCX2 VCX3A VCX	1.39e-04	115	39	3	c724e8b1fddcefdaa8d247aaff68c986538068f7
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	APC ANKRD12 ASH1L	2.38e-04	138	39	3	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	(04)_Pre-ciliated-(2)_48hpi\|(04)_Pre-ciliated / shred by cell type and Timepoint	DEK HMGN3 RPL4	3.60e-04	159	39	3	e1f36b237e314ef6a18224eb8f3b97a612c39506
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	PCSK1 MYLK CHRM2	3.67e-04	160	39	3	d783d29150033e9181c0e30870070268fed3fd85
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AEBP1 PRG4 SRRM4	4.02e-04	165	39	3	c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e
ToppCell	15-Airway-Mesenchymal-Airway_Smooth_Muscle\|Airway / Age, Tissue, Lineage and Cell class	TACC2 MYLK SRRM4	4.02e-04	165	39	3	531804467601e1ee1f771cffa21501f6d464ae10
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	MYLK CHRM2 H1-0	4.02e-04	165	39	3	7b992843bd8ef92a7a76b1d681fa84efde6f5bdd
ToppCell	facs-Kidney-nan-24m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AEBP1 PRG4 SRRM4	4.02e-04	165	39	3	4cdd80580d5638fd649280ba3893251c2f898f3f
ToppCell	tumor_Lung-B_lymphocytes-Undetermined\|tumor_Lung / Location, Cell class and cell subclass	RPL4 PRDM2 SETBP1	4.02e-04	165	39	3	3d010a66abac3961cc99f20b1459cf0eb0f7510d
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK AEBP1 CHRM2	4.09e-04	166	39	3	94636dbc039f794c735960c3425e00bdd5523602
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AEBP1 PRG4 CHRM2	4.16e-04	167	39	3	351f8de1fbdf742ac74f9099b254d515ab539bb2
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AEBP1 PRG4 CHRM2	4.16e-04	167	39	3	c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK AEBP1 PRG4	4.16e-04	167	39	3	f4943fb5001475ddab82a0273bcbb3fa68fdd7bd
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MACROH2A1 ERCC6L DEK	4.23e-04	168	39	3	b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc
ToppCell	PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ELK3 AEBP1 HMGN3	4.31e-04	169	39	3	f077e39e41fffe7672541f5b72b80faaf56c597c
ToppCell	PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ELK3 AEBP1 HMGN3	4.38e-04	170	39	3	35e3945d8a540a3e2cec1b559316265aaad023d1
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TACC2 AEBP1 SRRM4	4.38e-04	170	39	3	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	PND01-Endothelial-Endothelial_lymphatic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ELK3 AEBP1 HMGN3	4.38e-04	170	39	3	0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD12 PHACTR2 REEP3	4.38e-04	170	39	3	51dbfa07daf6f972b566f3f6abe7f46e080ec01c
ToppCell	PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ELK3 AEBP1 HMGN3	4.38e-04	170	39	3	0b5ddc7d452db0a389927a367914f7d257703f7e
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMGB1 HMGN3 H1-0	4.46e-04	171	39	3	621f9da0bfa09c86fc89fd26919403e94cd56d2b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	AEBP1 PRDM2 SETBP1	4.46e-04	171	39	3	a2938e56cb5749004317798dc7ac0f0c2d4d8ae0
ToppCell	ASK454-Epithelial-Transformed_epithelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	EPS15L1 REEP3 PCDH1	4.53e-04	172	39	3	3986f0f098ef5e096c8d9ee3d335b8404083701f
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Lymphocytic-T\|bone_marrow / Manually curated celltypes from each tissue	MACROH2A1 ERCC6L DEK	4.69e-04	174	39	3	1e289b26e2c29dbad15b712a999b96c391a26129
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGB1 NT5C1A DEK	4.69e-04	174	39	3	021ebc6ec022b992d7b25333ba0b7416371e041b
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HMGB1 NT5C1A DEK	4.69e-04	174	39	3	c2fc78dd6c440737ded59676961e4c7b923084ce
ToppCell	3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HMGB1 ERCC6L HMGN3	4.69e-04	174	39	3	46cbb462173a684ceb9e680f9259dc3b133763f7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK AEBP1 CHRM2	4.77e-04	175	39	3	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PCSK1 MAP6 SRRM4	4.77e-04	175	39	3	9941c35601134d88d1b3249c81f8b43a8fc61610
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AEBP1 CHRM2 C6orf132	4.85e-04	176	39	3	8e7f38de8bf68077e2138f4d06c1f55b0fd096cc
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AEBP1 CHRM2 C6orf132	4.85e-04	176	39	3	ed575330a08a6748ea4b28433292c8cfd157d444
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMGB1 ERCC6L DEK	4.93e-04	177	39	3	8a74f5e72de605774111057bd87a7e7e4a6385cd
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYLK CHRM2 SETBP1	4.93e-04	177	39	3	b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK1 MAP6 PRG4	4.93e-04	177	39	3	fd4a297e519b3959811a462d63feebff76429031
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-regulatory_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK1 MAP6 PRG4	4.93e-04	177	39	3	e995230ef207dcd87eab4550617589016ffa9970
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HMGB1 HMGN3 RPL4	5.01e-04	178	39	3	7975bf0a3146ee0efa4f547af5977e6bf0ba71fd
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	MYLK AEBP1 ARHGEF7	5.01e-04	178	39	3	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	AEBP1 PRG4 C6orf132	5.01e-04	178	39	3	1e05bc26591fea16e29bcfc5f538dda1dc427f05
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	MYLK ARHGEF7 SETBP1	5.09e-04	179	39	3	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYLK ARHGEF7 SETBP1	5.09e-04	179	39	3	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	AEBP1 PRG4 CHRM2	5.09e-04	179	39	3	10fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELK3 PHACTR2 PRDM2	5.18e-04	180	39	3	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK AEBP1 SRRM4	5.18e-04	180	39	3	d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELK3 PHACTR2 PRDM2	5.18e-04	180	39	3	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	COPD-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	MYLK PCDH1 CHRM2	5.26e-04	181	39	3	61608123959483ff60f07d8467996853c4371b6a
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	MYLK AEBP1 PRG4	5.26e-04	181	39	3	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK1 AEBP1 PRG4	5.35e-04	182	39	3	d179b5deb07c20d49eb6c58d5a65904f8921de3a
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK AEBP1 CHRM2	5.43e-04	183	39	3	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	Immune_cells-large_pre-B.\|World / Lineage and Cell class	HMGB1 MACROH2A1 HMGN3	5.43e-04	183	39	3	81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK AEBP1 CHRM2	5.43e-04	183	39	3	bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell	Mesenchymal_cells-Smooth_muscle\|Mesenchymal_cells / Lineage and Cell class	PCSK1 MYLK PCDH1	5.52e-04	184	39	3	83987abaedc26e6da477bc70d65e10b1ab1aea60
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK AEBP1 CHRM2	5.52e-04	184	39	3	7b5678718719020b52e7c2a7bd9797987defd7ff
ToppCell	COPD-Endothelial-VE_Capillary_A\|COPD / Disease state, Lineage and Cell class	MYLK PCDH1 CHRM2	5.52e-04	184	39	3	5f4f7775d488ececf086c71441defecbee9d8a9c
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK AEBP1 CHRM2	5.52e-04	184	39	3	54e5b63f55b8d6eccad53d389ea9c78f991e1414
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK1 PHACTR2 MYLK	5.61e-04	185	39	3	5a0340c25196453f19e424d346efbf66d2c53ac3
Drug	Methylnitronitrosoguanidine	APC HMGB1 ELK3 ABL1 MYLK DEK	6.47e-06	265	40	6	ctd:D008769
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	APC TACC2 ANKRD12 ARHGEF7 PRDM2	1.54e-05	180	40	5	4541_DN
Drug	colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA	PHF2 ANKRD12 PHACTR2 ABL1 ARHGAP35	1.99e-05	190	40	5	1103_UP
Drug	Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	APC MACROH2A1 XRCC1 ARHGEF7 EIF4G2	2.15e-05	193	40	5	3479_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	APC EPS15L1 ANKRD12 ARHGAP35 ASH1L	2.37e-05	197	40	5	4988_DN
Drug	Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; PC3; HT_HG-U133A	KIFAP3 EPS15L1 MYLK SETBP1 H1-0	2.37e-05	197	40	5	6288_DN
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	APC KIFAP3 MACROH2A1 ARHGAP35 PRDM2	2.49e-05	199	40	5	5321_DN
Drug	imidafenacin	MYLK CHRM2	4.49e-05	6	40	2	CID006433090
Disease	gallbladder cancer (is_implicated_in)	APC XRCC1	1.32e-04	13	39	2	DOID:3121 (is_implicated_in)
Disease	Glioma	APC XRCC1 MYLK	2.10e-04	87	39	3	C0017638
Disease	Neurodevelopmental Disorders	PHF2 SETBP1 ASH1L	2.55e-04	93	39	3	C1535926
Disease	chronic myeloid leukemia (is_implicated_in)	ABL1 XRCC1	3.52e-04	21	39	2	DOID:8552 (is_implicated_in)
Disease	transitional cell carcinoma (is_implicated_in)	APC XRCC1	3.87e-04	22	39	2	DOID:2671 (is_implicated_in)
Disease	proprotein convertase subtilisin/kexin type 9 measurement	PHACTR2 REEP3	3.87e-04	22	39	2	EFO_0009312
Disease	colorectal cancer (is_implicated_in)	APC ABL1 XRCC1	5.52e-04	121	39	3	DOID:9256 (is_implicated_in)
Disease	Myeloid Leukemia, Chronic	ABL1 SETBP1	6.76e-04	29	39	2	C0023473
Disease	Malignant neoplasm of liver	APC ABL1 ASH1L	8.78e-04	142	39	3	C0345904
Disease	Liver neoplasms	APC ABL1 ASH1L	8.78e-04	142	39	3	C0023903
Disease	Mesothelioma	APC XRCC1	1.35e-03	41	39	2	C0025500
Disease	revision of total hip arthroplasty, aseptic loosening	VCX2 VCX3B	1.42e-03	42	39	2	EFO_0010725, EFO_0020973
Disease	L2 Acute Lymphoblastic Leukemia	ABL1 XRCC1	2.00e-03	50	39	2	C0023453
Disease	Childhood Acute Lymphoblastic Leukemia	ABL1 XRCC1	2.16e-03	52	39	2	C0023452

Protein segments in the cluster

Peptide	Gene	Start	Entry
KSKQDTPALPPKKPA	EPS15L1	771	Q9UBC2
TCPPSKSSKTKPKKL	ASH1L	226	Q9NR48
NLAPKKKPKSPKPQN	NT5C1A	36	Q9BXI3
PKATKKPKEKPPKAT	AEBP1	136	Q8IUX7
SKAPTKKPKATPVKK	H1-0	131	P07305
PPAKKAKSPSQKKPV	MACROH2A1	131	O75367
VKMTKQPAKKKPPPS	CHRM2	366	P08172
KPVSPKSGTLKSPPK	ARHGEF7	246	Q14155
KPKPKSSPASKDTRP	ANKRD12	1051	Q6UB98
TVKKKPAPKTPPKAA	MYLK	1221	Q15746
PPKVEKPSVQSSKPK	MAP6	371	Q96JE9
KKKFKDPNAPKRPPS	HMGB1	86	P09429
SKGKKSKSPKPVKPV	PCDH1	911	Q08174
PPKPEPKPRKTSAKK	HMGN3	36	Q15651
KPKPKKSPVPPKGAT	PHACTR2	166	O75167
KPAPEKKPAEKKPTT	RPL4	406	P36578
IQEKPAKTSKKPPPS	EIF4G2	526	P78344
TKTPKSSSPALKPKP	C6orf132	431	Q5T0Z8
PKPSGKPLPKSKKTC	DEK	186	P35659
KKKKTAPTPPKRSSS	ABL1	606	P00519
KTKSPSLPPKAKKPK	ELK3	281	P41970
KEKKEKSSKPKDPPP	KIFAP3	106	Q92845
KKKCPKLNKPQPQPS	ERCC6L	741	Q2NKX8
FSCPKKPLSPPKKKV	PRDM2	1476	Q13029
KPLSPPKKKVSHSSK	PRDM2	1481	Q13029
PKKKKTGAPPAPSCK	REXO1	376	Q8N1G1
PSPSDPKKKTTKVAK	VCX3A	26	Q9NNX9
PSPSDPKKKTTKVAK	VCX3B	26	Q9H321
TVKMPKPSKIPKPPK	PHF2	496	O75151
KKKFKDPNAPKRPPS	HMGB1P1	86	B2RPK0
QPLPEAKKKSKPAPS	REEP3	171	Q6NUK4
TKKPKPKPRPSITKA	ARHGAP35	1226	Q9NRY4
STTKRSPKPPNKKKT	PRG4	131	Q92954
ATTPKPQKPTKAPKK	PRG4	1016	Q92954
PQKPTKAPKKPTSTK	PRG4	1021	Q92954
DGKKKKPTSPVKPIP	APC	1766	P25054
PSPSDPKKKTTKVAK	VCX2	26	Q9H322
TPPPSSRGKKKKKKS	SRRM4	101	A7MD48
RPPSLKKKQTTKKPT	TACC2	2131	O95359
PSPSDPKKKTTKVAK	VCX	26	Q9H320
PKLPQKQPQTKTKPT	XRCC1	426	P18887
PEPPTVGSKKKSSKK	SETBP1	326	Q9Y6X0
SKNSPPKQSPKKSPS	PCSK1	676	P29120